Posted in | News

Major Advances in NAND Flash Memory with 3-Bit-Per-Cell 32nm Generation and with 4-Bit-Per-Cell 43nm Technology

Toshiba Corporation (TOKYO:6502) today announced breakthroughs in multi-bit-per-cell technology for NAND flash memories that will bring advances in chip densities and cost savings to next generation devices. In the 32 nanometer (nm) generation, Toshiba has realized a 3-bit-per-cell 32 gigabit (Gb) chip with the world-smallest die size, and smaller than a 2-bit-per-cell 16Gb chip fabricated with 43nm technology, which is currently in the market. The cutting-edge chip will be mass produced in the second half of CY2009. The company has also fabricated the world's first 64Gb chip that applies 4-bit-per-cell technology at the 43 nm process generation.

Image of 3-bit-per cell, 32nm chip (Graphic: Business Wire)

Toshiba and its technology partner, SanDisk, unveiled these key technology advances today at the International Solid State Circuits Conference (ISSCC) now underway in San Francisco, California.

Manufacturers of NAND flash memories must respond to demand for higher density with lower costs. Toshiba and SanDisk have done so through the application of its innovative technologies.

The 3-bit-per-cell 32nm generation device uses optimized circuit design for the row decoder and extended column architecture, which significantly contributed to a 113mm2 chip, the smallest die size yet achieved in this generation. The 4-bit-per cell applies super multi-bit programming technologies, which realizes 64Gb without increase in chip size, while achieving a write speed performance of 7.8MB/s.

Toshiba and SanDisk have maintained their continuing leadership in the development and manufacturing of advanced NAND flash memory. Toshiba will promote further development in leading-edge process technologies to further widen the scope of application and to expand the NAND flash memory market.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.